Award Data

This Small Business Innovation Research (SBIR) Phase II project will provide a visual analytics platform that helps visualize how information spreads on the Web through networks of news outlets and social media users. The supported research will extend the interactive visual analytic platform by incorporating better influence modeling, sophisticated propagation cascade models that consider the sem ...

This SBIR Phase II project will develop a drug delivery technology to address the unmet need of antiproliferative drug delivery below-the-knee. In the United States, there are 323,000 new critical limb ischemia (CLI) patients each year. CLI is the most severe stage of peripheral artery disease (PAD), atherosclerosis of the lower limbs. Ultimately, 40% of CLI patients will undergo lower limb amputa ...

This Small Business Innovation Research (SBIR) Phase II project addresses the clinical and market need for an X-ray replacement technology that is portable, low-cost, and safe. While X-ray is the current dominant modality for diagnostic imaging of bone anatomy, it possesses many limitations: emission of radiation, bulky, and expensive. In the Phase I project, we demonstrated feasibility of the tec ...

The innovation, CUNAT (CUNeiform Automated Translator) attacks significant problems in a discipline wedded to conservative manual methods. Ancient Mesopotamian legal treatises, Egyptian medical records, and Roman political accounts--telling us exactly what happened in the words of the very people whose actions formed our history - languish untranslated, because there are too many of them, translat ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project extends to industry stakeholders holding financial interests that are impacted by climate change. Climate change has a scientifically evident impact on the intensity, duration, and frequency of extreme weather events. It has become imperative for organizations in all sectors to gain a clear u ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project focuses on using analytics and technology to benefit patients who require additional care to fully recover - or simply to maintain their health - after being discharged from the hospital. Whether subacute or community-based care, significant opportunity exists to leverage machine learning, de ...

This SBIR Phase II project focuses on creating scalable Virtual Learning Assistant technology for automatic educational assessments using open response questions. Educational researchers and experts believe that the best pedagogies responsible for improving students' learning outcomes involve (i) open response questions assessments and (ii) one-to-one instructional tutoring. Students learn better ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to develop an instrument platform that will facilitate development and translation of next generation diagnostics and therapeutics that are based on a class of nanovesicles called extracellular vesicles (EVs). EVs, which are nanoparticles shed by cells, are being investigated for early det ...

This SBIR Phase II project aims to transform intravenous (IV) infusions of biologic medicines into simple subcutaneous (SC) injections. Biologics have improved the treatment of human disease. Unfortunately, their delivery is burdensome. The standard of administration of these biologics is often by IV infusion at low concentrations, which can take multiple hours to deliver, cause patient discomfort ...

The broader impact/commercial potential of this Small Business Innovative Research (SBIR) Phase II project is a significant reduction in the cost and time to remove hazardous contaminants from the soils and groundwater impacting communities. Properties observed from thousands of contaminated sites serve as inputs to a computerized mathematical model of the site, forecasting the most likely shape a ...